Other Non-Current Liabilities
Markel Other Non-Current Liabilities decreased by 6.5% to $5.35B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.1%, from $4.45B to $5.35B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 14.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
Detailed definition
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peer comparison
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.35B | $3.53B | $3.83B | $3.74B | $3.30B | $3.29B | $3.46B | $3.42B | $3.60B | $3.59B | $3.93B | $3.96B | $3.98B | $4.43B | $4.97B | $4.45B | $4.63B | $4.74B | $5.72B | $5.35B |
| QoQ Change | — | +5.4% | +8.6% | -2.3% | -11.8% | -0.3% | +5.2% | -1.3% | +5.4% | -0.4% | +9.4% | +0.8% | +0.5% | +11.2% | +12.2% | -10.3% | +4.1% | +2.3% | +20.7% | -6.5% |
| YoY Change | — | — | — | — | -1.3% | -6.7% | -9.7% | -8.7% | +9.2% | +9.1% | +13.5% | +15.8% | +10.4% | +23.3% | +26.5% | +12.5% | +16.4% | +7.1% | +15.2% | +20.1% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Markel's other non-current liabilities?
- Markel (MKL) reported other non-current liabilities of $5.35B in Q1 2026.
- How has Markel's other non-current liabilities changed year-over-year?
- Markel's other non-current liabilities increased by 20.1% year-over-year, from $4.45B to $5.35B.
- What is the long-term trend for Markel's other non-current liabilities?
- Over 5 years (2020 to 2025), Markel's other non-current liabilities has grown at a 14.2% compound annual growth rate (CAGR), from $2.95B to $5.72B.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified under standard debt or liability categories.